A, G., S, C., R, P., S, L., S, R., BW, D., . . . AS, T. (2024). Time-course analysis of cisplatin induced AKI in preclinical models: Implications for testing different sources of MSCs. Journal of translational medicine, 22(1), 789. https://doi.org/10.1186/s12967-024-05439-6
Chicago Style (17th ed.) CitationA, Ganguly, et al. "Time-course Analysis of Cisplatin Induced AKI in Preclinical Models: Implications for Testing Different Sources of MSCs." Journal of Translational Medicine 22, no. 1 (2024): 789. https://doi.org/10.1186/s12967-024-05439-6.
MLA (9th ed.) CitationA, Ganguly, et al. "Time-course Analysis of Cisplatin Induced AKI in Preclinical Models: Implications for Testing Different Sources of MSCs." Journal of Translational Medicine, vol. 22, no. 1, 2024, p. 789, https://doi.org/10.1186/s12967-024-05439-6.